|
|
SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery
Marian Gutowski
,
Bérénice Framery
,
Martin Boonstra
,
Véronique Garambois
,
François Quenet
,
et al.
Article dans une revue
hal-02371819v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The HER3/ERBB3 receptor: the dark side of the ERBB planet
Christel Larbouret
,
Nadège Gaborit
,
Marie-Alix Poul
,
André Pèlegrin
,
Thierry Chardès
Article dans une revue
hal-02285139v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
Ghislaine Behar
,
Patrick Chames
,
Isabelle Teulon
,
Amélie Cornillon
,
Faisal Alshoukr
,
et al.
Article dans une revue
hal-00420547v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation
Christophe Le Clorennec
,
Yassamine Lazrek
,
Olivier Dubreuil
,
Christel Larbouret
,
Marie-Alix Poul
,
et al.
Article dans une revue
hal-02297403v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
David Azria
,
Frédéric Bibeau
,
Nicolas Barbier
,
Abderrahim Zouhair
,
Claire Lemanski
,
et al.
Article dans une revue
inserm-00090458v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
Michael Buchert
,
Marina Papin
,
Caroline Bonnans
,
Charbel Darido
,
Warren Raye
,
et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (6), pp.2628-2633. ⟨10.1073/pnas.0903747107⟩
Article dans une revue
hal-03108425v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Nina Radosevic-Robin
,
Wilhem Leconet
,
Myriam Chentouf
,
Stanislas Du Manoir
,
Clément Chevalier
,
et al.
Article dans une revue
hal-01676378v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Examination of HER3 targeting in cancer using monoclonal antibodies
Nadège Gaborit
,
Ali Abdul-Hai
,
Maicol Mancini
,
Moshit Lindzen
,
Sara Lavi
,
et al.
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112 (3), pp.839-844. ⟨10.1073/pnas.1423645112⟩
Article dans une revue
hal-02276327v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity
Jérôme Lacombe
,
Muriel Brengues
,
Alain Mangé
,
Céline Bourgier
,
Sophie Gourgou
,
et al.
Article dans une revue
hal-02371868v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6 th antibody industrial symposium, June 25-26, 2018, Montpellier, France
Pierre Martineau
,
Herve Watier
,
André Pèlegrin
,
Andrei Turtoi
Article dans une revue
hal-02448613v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.
Salomé Paillas
,
Laurent Boudou
,
Bérengère Piron
,
Nathalie Kersual
,
Manuel Bardiès
,
et al.
Article dans une revue
inserm-00815724v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial
Eric Assenat
,
David Azria
,
Caroline Mollevi
,
Rosine Guimbaud
,
Nicole Tubiana-Mathieu
,
et al.
Article dans une revue
hal-02005981v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures
Christel Larbouret
,
Laurent Gros
,
André Pèlegrin
,
Thierry Chardès
Article dans une revue
hal-03360265v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent
Charlotte Hoogstins
,
Leonora Boogerd
,
Babs Sibinga Mulder
,
J. Sven D. Mieog
,
Rutger Jan Swijnenburg
,
et al.
Article dans une revue
hal-02289226v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Anti-HER2 vaccines: new prospects for breast cancer therapy.
Maha Zohra Ladjemi
,
William Jacot
,
Thierry Chardès
,
André Pèlegrin
,
Isabelle Navarro-Teulon
Article dans une revue
inserm-00491487v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
[Anti-HER2 vaccines: The HER2 immunotargeting future?]
Maha-Zohra Ladjemi
,
William Jacot
,
André Pèlegrin
,
Isabelle Navarro-Teulon
Article dans une revue
inserm-00396298v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Bérénice Framery
,
Marian Gutowski
,
Karen Dumas
,
Alexandre Evrard
,
Nathalie Muller
,
et al.
Article dans une revue
hal-02931825v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
Emilia Rabia
,
Véronique Garambois
,
Julie Hubert
,
Marine Bruciamacchie
,
Nelly Pirot
,
et al.
Article dans une revue
hal-03360283v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Cell Membrane is a More Sensitive Target than Cytoplasm to Dense Ionization Produced by Auger Electrons.
Jean-Pierre Pouget
,
Lore Santoro
,
Laure Raymond
,
Nicolas Chouin
,
Manuel Bardiès
,
et al.
Article dans une revue
inserm-00311037v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy.
Bérengère Piron
,
Salomé Paillas
,
Vincent Boudousq
,
André Pèlegrin
,
Caroline Bascoul-Mollevi
,
et al.
Article dans une revue
inserm-00981411v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The human Mullerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4
Nathalie Kersual
,
Véronique Garambois
,
Thierry Chardès
,
Jean-Pierre Pouget
,
Imed Salhi
,
et al.
Article dans une revue
hal-02168055v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.
Vincent Boudousq
,
Stéphanie Ricaud
,
Véronique Garambois
,
Caroline Bascoul-Mollevi
,
Samir Boutaleb
,
et al.
Article dans une revue
inserm-00531603v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
[Bispecific antibodies: what future?]
André Pèlegrin
,
Bruno Robert
Article dans une revue
inserm-00446432v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy
Céline Bourgier
,
Jérôme Lacombe
,
Jérôme Solassol
,
Alain Mangé
,
André Pèlegrin
,
et al.
Article dans une revue
hal-02148578v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial
David Azria
,
Olivier Riou
,
Florence Castan
,
Tan Dat Nguyen
,
Karine Peignaux
,
et al.
Article dans une revue
hal-02338826v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Synthesis of new cyclic RGD peptides for specific tumor cell targeting.
Florine Cavelier
,
Julien Schmidt
,
Luc Rocheblave
,
Jean Martinez
,
André Pèlegrin
,
et al.
Peptides, 2006, pp.600
Article dans une revue
hal-00117023v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.
Lore Santoro
,
Samir Boutaleb
,
Véronique Garambois
,
Caroline Bascoul-Mollevi
,
Vincent Boudousq
,
et al.
Article dans une revue
inserm-00442929v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Pauline Estupina
,
Alexandre Fontayne
,
Jean-Marc Barret
,
Nathalie Kersual
,
Olivier Dubreuil
,
et al.
Article dans une revue
hal-02379710v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cells.
Caroline Rozan
,
Amélie Cornillon
,
Corinne Petiard
,
M. Chartier
,
G. Behar
,
et al.
Article dans une revue
hal-02454959v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers
Catherine Lozza
,
Isabelle Navarro-Teulon
,
André Pèlegrin
,
Jean-Pierre Pouget
,
Eric Vivès
Article dans une revue
hal-03824440v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|